☆ 4.1 Article

Hemophagocytic Lymphohistiocytosis Following COVID-19 Infection

CUREUS JOURNAL OF MEDICAL SCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination

Ermias D. Belay et al.

Summary: From December 14, 2020, to April 30, 2021, 20 patients with MIS-A were reported to CDC. The median age was 35 years, with 65% being male. 80% had a preceding COVID-19-like illness before MIS-A onset. All patients had laboratory evidence of prior SARS-CoV-2 infection.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Review Rheumatology

Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic

Mehmet Soy et al.

Summary: Hemophagocytic syndrome (HPS) or hemophagocytic lymphohistiocytosis (HLH) is an acute systemic inflammatory disorder characterized by excessive cytokine production and hyperferritinemia. It can be primary, caused by genetic mutations, or secondary, triggered by underlying disorders like malignancies or infections. In COVID-19 patients, secondary HLH and cytokine storm may lead to severe symptoms such as progressive fever, cytopenia, ARDS, and organ failure. Early differentiation and classification are crucial for appropriate treatment strategies.

RHEUMATOLOGY INTERNATIONAL (2021)

Add to Collection

Article Infectious Diseases

Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients

Mei Meng et al.

Summary: This study found that a high HScore (>98) is an independent predictor of poor outcomes in COVID-19 patients, while high ferritin, low platelets, and high triglycerides are independent risk factors for developing secondary sHLH in COVID-19 patients.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Virology

Cytokine storm in severe COVID-19 pneumonia

Bengul Gursoy et al.

Summary: This study compared laboratory parameters of 150 confirmed COVID-19 patients with severe pneumonia, showing significant abnormalities in patients with pneumonia. Findings revealed marked changes in lymphocyte levels, LDH elevation, and other parameters in patients with severe pneumonia before and after its development. Additionally, a significant decrease in lymphocyte levels and increases in LDH, hs-troponin, procalcitonin, and triglyceride levels were observed in patients with worsened symptoms and developed ARDS in the ICU period.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report

Marco Meazza Prina et al.

Summary: This case report describes a woman diagnosed with sHLH related to previous Sars-CoV-2 infection and successfully treated with steroids, colchicine, etoposide, and ruxolitinib. It suggests that HLH-like syndrome might be secondary to Sars-CoV-2 infection even after complete recovery from mild symptoms. The treatment with low dose ruxolitinib plus etoposide could be a potential choice for Sars-CoV-2 infection related HLH.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Secondary Hemophagocytic Lymphohistiocytosis in Post-COVID-19 Patients: A Report of Two Cases

Pranjal Kalita et al.

Summary: HLH can affect both children and adults, categorized as primary or secondary. Post-COVID-19 patients who have recovered may present with sHLH due to dysregulation of the immune system.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Add to Collection

Review Medicine, Research & Experimental

Immunopathogenesis and treatment of cytokine storm in COVID-19

Jae Seok Kim et al.

Summary: Severe COVID-19 is characterized by systemic hyper-inflammation and cytokine storm, often leading to acute respiratory distress syndrome and multiple organ failure. Treatment of COVID-19 cytokine storm is crucial, with anti-inflammatory therapies playing a significant role. Various approaches are being used, including new cytokine-targeted therapies, to address the cytokine storm associated with COVID-19.

THERANOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Article Critical Care Medicine

Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore

Cornelia Knaak et al.

CRITICAL CARE (2020)

Add to Collection

Article Hematology

Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH

Anna Hayden et al.

BLOOD ADVANCES (2017)

Add to Collection

Review Rheumatology

Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis

Lehn K. Weaver et al.

CURRENT OPINION IN RHEUMATOLOGY (2014)

Add to Collection

Article Medicine, General & Internal

Adult haemophagocytic syndrome

Manuel Ramos-Casals et al.

LANCET (2014)

Add to Collection

Review Pathology

Hemophagocytic Lymphohistiocytosis An Update on Diagnosis and Pathogenesis

Flavia G. N. Rosado et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)

Add to Collection

Review Oncology

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

Jan-Inge Henter et al.

PEDIATRIC BLOOD & CANCER (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.